87 related articles for article (PubMed ID: 1657141)
1. Conformation-activity relationship of tachykinin neurokinin A (4-10) and of some [Xaa8] analogues.
Saviano G; Temussi PA; Motta A; Maggi CA; Rovero P
Biochemistry; 1991 Oct; 30(42):10175-81. PubMed ID: 1657141
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality.
Warner FJ; Mack P; Comis A; Miller RC; Burcher E
Biochem Pharmacol; 2001 Jan; 61(1):55-60. PubMed ID: 11137709
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of neurokinin A.
Rovero P; Pestellini V; Rhaleb NE; Dion S; Rouissi N; Tousignant C; Télémaque S; Drapeau G; Regoli D
Neuropeptides; 1989; 13(4):263-70. PubMed ID: 2546091
[TBL] [Abstract][Full Text] [Related]
5. Binding and functional potency of neurokinin A analogues in the rat fundus: A structure-activity study.
Matuszek MA; Comis A; Burcher E
Pharmacology; 1999 May; 58(5):227-35. PubMed ID: 10087463
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
Hellstrom PM; Murthy KS; Grider JR; Makhlouf GM
J Pharmacol Exp Ther; 1994 Jul; 270(1):236-43. PubMed ID: 8035320
[TBL] [Abstract][Full Text] [Related]
7. Solution conformation of c-[Gln-Trp-Phe-Gly-Leu-Met], a NK-2 tachykinin antagonist.
Amodeo P; Rovero P; Saviano G; Temussi PA
Int J Pept Protein Res; 1994 Dec; 44(6):556-61. PubMed ID: 7705977
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the existence of NK2 tachykinin receptor subtypes.
Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological activity, and conformational analysis of [pGlu6,N-MePhe8,Aib9] substance P (6-11): a selective agonist for the NK-3 receptor.
Tallon M; Ron D; Halle D; Amodeo P; Saviano G; Temussi PA; Selinger Z; Naider F; Chorev M
Biopolymers; 1993 Jun; 33(6):915-26. PubMed ID: 7686410
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
Aharony D; Little J; Powell S; Hopkins B; Bundell KR; McPheat WL; Gordon RD; Hassall G; Hockney R; Griffin R
Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992
[TBL] [Abstract][Full Text] [Related]
11. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
12. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
13. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor.
Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E
Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
17. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
19. Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.
Gembitsky DS; Murnin M; Otvös FL; Allen J; Murphy RF; Lovas S
J Med Chem; 1999 Jul; 42(15):3004-7. PubMed ID: 10425111
[TBL] [Abstract][Full Text] [Related]
20. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
